|Last Price$0.02||Day Change (%)-0.79%|
|Open Price$0.02||Day Change ($)0.00|
|Day Range0.02–0.02||52-Week Range0.02–0.18|
As of Wed 11/26/2014 02:50 PM | USD
Research and Markets: Australia General Surgery Market Outlook to 2020: Key players covered include Olympus, Ethicon, Covidien, B. Braun Melsungen, C.R. Bard, and KARL STORZ GmbH & Co
Research and Markets: France General Surgery Market Outlook to 2020: Key players covered include Olympus, Ethicon, Covidien, B. Braun Melsungen, C.R. Bard, and KARL STORZ GmbH & Co
Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...
NEC and Texas State University Sign MOU to Collaborate on Social Infrastructure Projects
Renesas Electronics Reports Financial Results for the Second Quarter Ended September 30, 2014
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
The corporate bond market will probably struggle to return much above break-even in 2014.
Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.